Drugs / GSK3074477
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02075619 | Mar → Jul 2014 | hypertensive disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3074477 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02075619 ↗ |
| Route | Oral | “all treatments will be administered orally in fasted state.” NCT02075619 ↗ |